Three Years of Glome International: Bridging Healthcare Across Borders
On August 18, 2026, Glome International, a subsidiary of Glome Holdings (TSE Code: 8938), proudly celebrated its third anniversary. Established in August 2023, Glome International is driven by the mission that "there are no borders in healthcare," facilitating medical coordination between patients residing abroad and healthcare institutions in Japan.
Growth and Achievements
In the three years since its inception, the number of overseas visitors to Japan has rebounded significantly. The Japan National Tourism Organization (JNTO) forecasts that the number of foreign visitors in 2024 will reach 36.87 million, a remarkable increase of nearly five million compared to 2019. This surge in visitors is not limited to tourism; it has also broadened the horizon for medical inbound needs, including health check-ups and treatments.
Facing this milestone, Glome International continues to enhance the system that allows overseas patients to receive medical care in Japan with confidence. The organization aims to strengthen its business foundation through collaboration with its extensive medical network.
Leadership Insights
Masayuki Sugawara, CEO, articulated the company's dedication by stating, "We deliver Japanese healthcare beyond borders to those in need. Glome International's work involves a cumulative commitment to engage carefully with each patient. As we celebrate three years since our establishment, we strive to be a trusted bridge between Japanese healthcare institutions and international patients."
Service Offerings
Glome International provides various services targeting patients living abroad wishing to consult or receive treatment in Japan:
1.
Introduction to Domestic Medical Institutions: We connect overseas patients with medical facilities in Japan based on their needs and purposes for seeking treatment.
2.
Online Medical Consultation Services: For patients who require consultations without coming to Japan, we guide them to healthcare providers that offer online consultations.
3.
Medical Coordination Services: We support patients through comprehensive coordination—hence facilitating everything from initial inquiries and medical institution selection to adjustment, support for traveling to Japan, and receiving care.
For those overseas, the journey toward receiving treatment in Japan often begins with uncertainty about which medical institution to approach and how to proceed. Glome International strives to provide a seamless experience by managing the entire process: from consultations and selecting the right healthcare facility to offering assistance during medical visits.
Industry Context: The Expanding Medical Inbound Landscape
The Japanese government has been proactive in accepting overseas patients, introducing the medical stay visa in 2011. With ongoing economic growth, especially in Asia, an increasing number of patients are crossing borders in quest of high-quality medical care, particularly in health check-ups, cancer treatment, aesthetic medicine, and advanced treatments. Providing access to Japanese medical resources serves as an opportunity for healthcare facilities to fulfill a new role in the global landscape.
However, challenges such as language barriers, differences in medical systems, and access to healthcare institutions pose significant hurdles for overseas patients. As the demand for visiting Japan grows, the importance of specialized coordination services that can effectively eliminate these barriers is also on the rise.
Glome International's Positioning within the Group
Glome International acts as a bridge, facilitating access to Japanese healthcare for overseas patients while providing local medical institutions with opportunities to welcome new patients from abroad. This initiative connects domestic medical resources to international patient needs, offering a broadening scope for the group's medical-related businesses, while also conveying the value of Japanese healthcare services to a global audience.
Shareholder Benefits
In May 2025, Glome Holdings announced the introduction of a shareholder benefit program. This initiative, aimed at shareholders holding over 100 shares, will offer discount vouchers redeemable for medical services at affiliated institutions (applicable only for non-insured medical services). Through this program, Glome International seeks to provide shareholders with a firsthand experience of its medical offerings.
Company Overview
- - Established: August 18, 2023
- - Capital: 990 million yen
- - Shareholder Composition: 100% owned by Glome Holdings
- - CEO: Masayuki Sugawara
- - Location: Ark Mori Building 31st Floor, 1-12-32 Akasaka, Minato-ku, Tokyo, Japan
- - Business Focus: Introduction of medical institutions, online consultations, medical coordination services.
- - Official Website: Glome International
About Glome Holdings Inc.
Glome Holdings focuses on medical-related businesses alongside real estate and industrial storage projects, listed on the Tokyo Stock Exchange's Growth Market (TSE Code: 8938). The group remains committed to resolving societal challenges and enhancing sustainable corporate value through diverse business reach.